BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30354907)

  • 1. Prognostic values of ADC
    Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
    J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between DW-MRI and
    Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ability of post-chemoradiotherapy DWI ADC
    Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of FIGO staging defined by combining MRI and [
    Raffa S; Lanfranchi F; Satragno C; Giannelli F; Marcenaro M; Coco A; Cena SE; Sofia L; Marini C; Mammoliti S; Levaggi A; Tagliafico AS; Sambuceti G; Barra S; Morbelli S; Belgioia L; Bauckneht M
    Curr Probl Cancer; 2023 Dec; 47(6):101007. PubMed ID: 37684197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of
    Lv J; Yin H; Yu H; Shi H
    Abdom Radiol (NY); 2023 Jul; 48(7):2331-2339. PubMed ID: 37119293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.
    Wong KH; Panek R; Welsh L; Mcquaid D; Dunlop A; Riddell A; Murray I; Du Y; Chua S; Koh DM; Bhide S; Nutting C; Oyen WJ; Harrington K; Newbold KL
    J Nucl Med; 2016 Dec; 57(12):1843-1850. PubMed ID: 27417648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
    Wong KH; Panek R; Dunlop A; Mcquaid D; Riddell A; Welsh LC; Murray I; Koh DM; Leach MO; Bhide SA; Nutting CM; Oyen WJ; Harrington KJ; Newbold KL
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):759-767. PubMed ID: 29164301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory radiomic features from integrated
    Baiocco S; Sah BR; Mallia A; Kelly-Morland C; Neji R; Stirling JJ; Jeljeli S; Bevilacqua A; Cook GJR; Goh V
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1478-1484. PubMed ID: 30919055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of multiparametric MRI combined with clinical prognostic parameters in predicting the 5-year survival of stage IIIC1 cervical squamous cell carcinoma.
    Qin F; Pang H; Ma J; Xu H; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2023 Dec; 169():111181. PubMed ID: 37939604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between
    Ozen A; Sayin T; Kandemir O; Ekmekcioglu O; Altınay S; Bastug E; Muhammedoglu A; Celik A; Albayrak R
    Asia Ocean J Nucl Med Biol; 2024; 12(1):11-20. PubMed ID: 38164229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer.
    Atsumi K; Nakamura K; Abe K; Hirakawa M; Shioyama Y; Sasaki T; Baba S; Isoda T; Ohga S; Yoshitake T; Shinoto M; Asai K; Honda H
    J Radiat Res; 2013 Sep; 54(5):890-8. PubMed ID: 23520267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the maximum standardized uptake value for the diagnosis and staging of patients with cervical cancer undergoing positron emission tomography/computed tomography.
    Takagi H; Sakamoto J; Osaka Y; Shibata T; Fujita S; Sasagawa T
    Medicine (Baltimore); 2018 Feb; 97(7):e9856. PubMed ID: 29443749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
    Knoth J; Pötter R; Jürgenliemk-Schulz IM; Haie-Meder C; Fokdal L; Sturdza A; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Wiebe E; Rai B; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Sundset M; Tan LT; Nout RA; Tanderup K; Kirisits C; Nesvacil N; Lindegaard JC; Schmid MP
    Gynecol Oncol; 2020 Oct; 159(1):136-141. PubMed ID: 32798000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
    Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.
    Yang F; Thomas MA; Dehdashti F; Grigsby PW
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):716-27. PubMed ID: 23340594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.
    Prezzi D; Muthuswamy K; Amlani A; Owczarczyk K; Elowaidy A; Mistry T; Bassett P; Goh V
    Eur Radiol; 2023 Nov; 33(11):7575-7584. PubMed ID: 37462820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient survival prediction in locally advanced cervical squamous cell carcinoma using MRI-based radiomics: retrospective cohort study.
    Bseiso A; Saqib M; Saigol MS; Rehman A; Sare A; Yagoub AE; Mumtaz H
    Ann Med Surg (Lond); 2023 Nov; 85(11):5328-5336. PubMed ID: 37915655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factor-based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix.
    Liu FY; Chen WC; Pan YB; Wang CC; Tang YH; Chou HH; Chao A; Yang LY; Lai CH
    Cancer Med; 2024 Jan; 13(1):. PubMed ID: 38192162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activity of primary tumour on PET/CT has a relationship with survival in stages I-III small-cell lung carcinoma.
    Özdemir Ö; Batum Ö; Ermin S; Aksel N; Kömürcüoğlu B; Mertoğlu A; Deniz S; Balcı G; Koparal H; Özbilek E; Yılmaz U
    Clin Respir J; 2020 Aug; 14(8):695-702. PubMed ID: 32170990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.